Tejas Cargo IPO - Day 3 Subscription at 0.77 Times
Dr Agarwals Healthcare IPO Anchor Allocation at 28.92%


Last Updated: 3rd February 2025 - 03:59 pm
Dr Agarwals Healthcare IPO received a notable anchor allocation response, with 28.92% of the total IPO size subscribed by anchor investors. Out of the 7,53,04,970 shares on offer, anchors picked up 2,17,78,798 shares, showing strong institutional interest. The anchor allocation details were reported to the stock exchanges on January 28, 2025, preceding the IPO opening on January 29, 2025.
The book-built issue of ₹3,027.26 crores comprises a fresh issue of 74,62,686 shares aggregating to ₹300 crores and an offer for sale of 6,78,42,284 shares aggregating to ₹2,727.26 crores. The price band is set at ₹382 to ₹402 per share, with a face value of ₹1 per share. This includes a share premium of ₹401 per share at the upper end of the price band.
The anchor allocation process, which took place on January 28, 2025, witnessed strong participation from institutional investors. The entire anchor allocation was made at the upper end of the price band, ₹402 per share, indicating robust demand and confidence in the company's prospects.
i Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!
After the anchor allocation, the overall allocation of the IPO looks as follows:
Category | Shares Offered | Allocation (%) |
Anchor Investor | 2,17,78,798 | 28.92% |
Qualified Institutional Buyers (QIB) | 1,45,19,200 | 19.28% |
Non-Institutional Investors (NII) | 1,08,89,400 | 14.46% |
bNII (> ₹10L investment) | 72,59,600 | 9.64% |
sNII (< ₹10L investment) | 36,29,800 | 4.82% |
Retail Investors | 2,54,08,599 | 33.74% |
Employees | 15,79,399 | 2.10% |
Others | 11,29,574 | 1.50% |
Total | 7,53,04,970 | 100% |
The lock-in period for anchor investors is an important aspect of the allocation. For Dr Agarwals Healthcare IPO, the lock-in details are as follows:
- Lock-in Period (50% Shares): March 5, 2025
- Lock-in Period (Remaining Shares): May 4, 2025 This lock-in period ensures that anchor investors maintain their investments for a specified duration, stabilizing the stock price after listing.
Anchor Investors in Dr Agarwals Healthcare IPO
Anchor investors are typically large institutional investors allotted shares in an IPO before it opens to the public. The anchor allocation process is a crucial part of the IPO, as it helps in price discovery and builds confidence among retail investors. The strong response from anchor investors often sets a positive tone for the public issue and can influence the overall subscription levels.
On January 28, 2025, Dr Agarwals Healthcare IPO completed the bidding for its anchor allocation. There was a robust response as 43 anchor investors participated in the book-building process. A total of 2,17,78,798 shares were allotted to anchor investors. The allocation was done at the upper IPO price band of ₹402 per share, resulting in an overall anchor allocation of ₹875.51 crores. The anchors have already absorbed 28.92% of the total issue size of ₹3,027.26 crores, indicating strong institutional demand.
Agarwals Healthcare IPO Key Details:
- IPO Size: ₹3,027.26 crores
- Shares Allocated to Anchors: 2,17,78,798
- Anchor Subscription Percentage: 28.92%
- Listing Date: February 4, 2025
- IPO Opening Date: January 29, 2025
About Dr Agarwals Healthcare Limited and How to Apply for Dr Agarwals Healthcare IPO
Incorporated in 2010, Dr Agarwals Healthcare Limited is a leading eye care services provider offering comprehensive eye care services, including cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. As of September 30, 2024, the company had 737 doctors providing care across 193 facilities in India spanning 14 states and four union territories. The company served 2.13 million patients and performed 220,523 surgeries during this period. Their network includes 28 hubs (Tertiary Facilities, including three Centers of Excellence) and 165 spokes (53 Primary and 112 Secondary Facilities).
- Flat ₹20 Brokerage
- Next-gen Trading
- Advance Charting
- Actionable Ideas
Trending on 5paisa
02
5paisa Research Team
03
5paisa Research Team
IPOs Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.